WILSON GLYNN - Insider Non-Derivative Transactions at Cadrenal Therapeutics, Inc. (CVKD) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 24, 2023, WILSON GLYNN's relationship to Cadrenal Therapeutics, Inc. (CVKD) is Director, and currently has 50,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CVKD insiders.
Data Source: SEC.
WILSON GLYNN - Insider Non-Derivative Transactions at CVKD
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 25, 2023 | C -- (Common Stock) | 50000 | 0 | 50000 |